DETERMINE is a cutting edge UK national precision medicine trial in rare cancers, testing a range of therapies specifically targeting key genetic changes in cancer cells.
Press releases
Read the story of one patient (from the Observer)
News
DETERMINE is finalist in one of the categories of the SCRIPT AWARD: COMMUNITY PARTNERSHIP OF THE YEAR
Press releases
News
DETERMINE has received the Foster Age Inclusivity Research (FAIR) for Adolescents and Young Adults (AYA) Stamp as recognition of good model of age inclusivity led by academics and supported by different pharmaceutical companies.
News
DETERMINE has won BioNow Healthcare project of the year!
